ArticleDEN open2027
Localized Gastrointestinal Light Chain (AL) Amyloidosis Under Surveillance for Five Years: A Case Report.
Article in DEN open, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amyloidosis, characterized by the deposition of abnormal protein fibrils in organs, is classified as systemic or localized. Amyloid light chain (AL)-type localized amyloidosis is uncommon, particularly when confined to the gastrointestinal tract. Herein, we report a case of localized gastrointestinal AL-type amyloidosis that was incidentally detected and remained endoscopically and clinically stable over a 5-year follow-up period. The patient, a man in his 40s, had undergone a colonoscopy for colorectal cancer screening, during which scattered erosions were detected in the colon. Amyloid deposits were identified on biopsy. No cardiac or renal involvement, or evidence of multiple myeloma, was found. He was ultimately diagnosed with localized AL-type gastrointestinal amyloidosis. Following diagnosis, the patient underwent regular surveillance with transoral and transanal small-bowel endoscopy. No endoscopic progression or gastrointestinal symptoms were observed during the follow-up period, and the patient remained asymptomatic. This case suggests that conservative observation may be reasonable in carefully selected patients after exclusion of systemic involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.